Plasma Angiotensin Converting Enzyme 2 (ACE2) Activity in Healthy Controls and Patients with Cardiovascular Risk Factors and/or Disease
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Plasma Angiotensin Converting Enzyme 2 (ACE2) Activity in Healthy Controls and Patients with Cardiovascular Risk Factors and/or Disease
Authors
Keywords
-
Journal
Journal of Personalized Medicine
Volume 12, Issue 9, Pages 1495
Publisher
MDPI AG
Online
2022-09-14
DOI
10.3390/jpm12091495
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global coagulation assays in hypercoagulable states
- (2022) Hui Yin Lim et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection
- (2022) Chansavath Phetsouphanh et al. NATURE IMMUNOLOGY
- The Need for Individualized Risk Assessment in Cardiovascular Disease
- (2022) Hui Yin Lim et al. Journal of Personalized Medicine
- Plasma ACE2 activity is persistently elevated following SARS-CoV-2 infection: implications for COVID-19 pathogenesis and consequences
- (2021) Sheila K. Patel et al. EUROPEAN RESPIRATORY JOURNAL
- Global coagulation assays in healthy controls: are there compensatory mechanisms within the coagulation system?
- (2021) Hui Yin Lim et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Biomarkers of coagulation, endothelial function, and fibrinolysis in critically ill patients with COVID‐19: A single‐center prospective longitudinal study
- (2021) Ganeem K. Juneja et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Genetic variant in 3’ untranslated region of the mouse pycard gene regulates inflammasome activity
- (2021) Brian Ritchey et al. eLife
- Acyl-Coenzyme A: Cholesterol Acyltransferase (ACAT) in Cholesterol Metabolism: From Its Discovery to Clinical Trials and the Genomics Era
- (2021) Qimin Hai et al. Metabolites
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Coagulopathy in COVID‐19
- (2020) Toshiaki Iba et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Incidence of thrombotic complications in critically ill ICU patients with COVID-19
- (2020) F.A. Klok et al. THROMBOSIS RESEARCH
- Plasma ACE2 and risk of death or cardiometabolic diseases: a case-cohort analysis
- (2020) Sukrit Narula et al. LANCET
- Role of Renin-Angiotensin System Components in Atherosclerosis: Focus on Ang-II, ACE2, and Ang-1–7
- (2020) Gabriela M. Silva et al. Frontiers in Physiology
- A review of global coagulation assays — Is there a role in thrombosis risk prediction?
- (2019) Hui Yin Lim et al. THROMBOSIS RESEARCH
- Myeloid Acat1/Soat1 KO attenuates pro-inflammatory responses in macrophages and protects against atherosclerosis in a model of advanced lesions
- (2019) Elaina M. Melton et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Plasma ACE2 Activity Predicts Mortality in Aortic Stenosis and Is Associated With Severe Myocardial Fibrosis
- (2019) Jay Ramchand et al. JACC-Cardiovascular Imaging
- Renin-Angiotensin System and Cardiovascular Functions
- (2018) Chia-Hua Wu et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Elevated plasma angiotensin converting enzyme 2 activity is an independent predictor of major adverse cardiac events in patients with obstructive coronary artery disease
- (2018) Jay Ramchand et al. PLoS One
- Quantitative Trait Locus Mapping of Macrophage Cholesterol Metabolism and CRISPR/Cas9 Editing Implicate an ACAT1 Truncation as a Causal Modifier Variant
- (2017) Qimin Hai et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Circulating angiotensin converting enzyme 2 activity as a biomarker of silent atherosclerosis in patients with chronic kidney disease
- (2016) Lidia Anguiano et al. ATHEROSCLEROSIS
- Angiotensin converting enzyme 2 activity and human atrial fibrillation: increased plasma angiotensin converting enzyme 2 activity is associated with atrial fibrillation and more advanced left atrial structural remodelling
- (2016) Tomos E. Walters et al. EUROPACE
- Circulating ACE2 activity correlates with cardiovascular disease development
- (2016) K. Uri et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Circulating angiotensin-converting enzyme 2 activity in patients with chronic kidney disease without previous history of cardiovascular disease
- (2015) Lidia Anguiano et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Inverse association of the endogenous thrombin potential (ETP) with cardiovascular death: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study
- (2014) Jochen G. Schneider et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- New Perspectives in the Renin-Angiotensin-Aldosterone System (RAAS) IV: Circulating ACE2 as a Biomarker of Systolic Dysfunction in Human Hypertension and Heart Failure
- (2014) Katalin Úri et al. PLoS One
- The role of tissue factor pathway inhibitor in atherosclerosis and arterial thrombosis
- (2013) Kristien Winckers et al. BLOOD REVIEWS
- Angiotensin-converting enzyme 2 activity in patients with chronic kidney disease
- (2013) M. A. Roberts et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Angiotensin converting enzyme 2 and atherosclerosis
- (2012) Yutang Wang et al. ATHEROSCLEROSIS
- Angiotensin-Converting Enzyme 2 Deficiency in Whole Body or Bone Marrow–Derived Cells Increases Atherosclerosis in Low-Density Lipoprotein Receptor −/− Mice
- (2011) Sean E. Thatcher et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Circulating ACE2 activity is increased in patients with type 1 diabetes and vascular complications
- (2011) Aino Soro-Paavonen et al. JOURNAL OF HYPERTENSION
- Microvascular Responses to Cardiovascular Risk Factors
- (2010) D. NEIL GRANGER et al. MICROCIRCULATION
- Overexpression of ACE2 Enhances Plaque Stability in a Rabbit Model of Atherosclerosis
- (2008) Bo Dong et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Von Willebrand Factor in Cardiovascular Disease
- (2008) Alexander O. Spiel et al. CIRCULATION
- General Cardiovascular Risk Profile for Use in Primary Care
- (2008) Ralph B. D’Agostino et al. CIRCULATION
- Angiotensin-converting enzyme 2 catalytic activity in human plasma is masked by an endogenous inhibitor
- (2008) Rebecca A. Lew et al. EXPERIMENTAL PHYSIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now